Lexicon Pharmaceuticals Inc

NASDAQ:LXRX  
1.15
+0.04 (+3.60%)
7:59:59 PM EDT: $1.15 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)417.89M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$4.65 Million
Adjusted EPS-$0.07
See more estimates
10-Day MA$1.11
50-Day MA$1.12
200-Day MA$0.78
See more pivots

Lexicon Pharmaceuticals Inc Stock, NASDAQ:LXRX

2445 Technology Forest Boulevard, 11th floor, The Woodlands, Texas 77381-1160
United States of America
Phone: +1.281.863.3000
Number of Employees: 103

Description

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.